Intercept thesis unchanged with pushed out data, says Summer Street Summer Street said it sees no reason to change its thesis on shares of Intercept after the company said the FLINT data is likely to be released in August, from July previously. The firm believes the data could represent a "significant positive catalyst" for the stock, and it thinks the potential for breakthrough designation on positive data remains a "very real possibility." Summer Street reiterates a Buy rating on Intercept with a $650 price target.
News For ICPT From The Last 14 Days
Check below for free stories on ICPT the last two weeks.